RT2 PCR array screening reveals distinct perturbations in DNA damage response signaling in FUS-associated motor
Haibo Wang1,2, Suganya Rangaswamy1, Manohar Kodavati1,2
1Department of Radiation Oncology, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Abstract:
Amyotrophic lateral sclerosis (ALS) is a degenerative motor neuron disease that has been linked to defective DNA repair. Many familial ALS patients harbor autosomal dominant mutations in the gene encoding the RNA/DNA binding protein 'fused in sarcoma' (FUS) commonly inducing its cytoplasmic mislocalization. Recent reports from our group and others demonstrate a role of FUS in maintaining genome integrity and the DNA damage response (DDR). FUS interacts with many DDR proteins and may regulate their recruitment at damage sites. Given the role of FUS in RNA transactions, here we explore whether FUS also regulates the expression of DDR factors. We performed RT2 PCR arrays for DNA repair and DDR signaling pathways in CRISPR/Cas9 FUS knockout (KO) and shRNA mediated FUS knockdown (KD) cells, which revealed significant (> 2-fold) downregulation of BRCA1, DNA ligase 4, MSH complex and RAD23B. Importantly, similar perturbations in these factors were also consistent in motor neurons differentiated from an ALS patient-derived induced pluripotent stem cell (iPSC) line with a FUS-P525L mutation, as well as in postmortem spinal cord tissue of sporadic ALS patients with FUS pathology. BRCA1 depletion has been linked to neuronal DNA double-strand breaks (DSBs) accumulation and cognitive defects. The ubiquitin receptor RAD23 functions both in nucleotide excision repair and proteasomal protein clearance pathway and is thus linked to neurodegeneration. Together, our study suggests that the FUS pathology perturbs DDR signaling via both its direct role and the effect on the expression of DDR genes. This underscors an intricate connections between FUS, genome instability, and neurodegeneration.
Insights
Fused in sarcoma (FUS) protein pathology in amyotrophic lateral sclerosis (ALS) disrupts DNA damage response (DDR) by downregulating key DDR genes, contributing to neurodegeneration. This highlights FUS
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease often linked to DNA repair defects.
- Mutations in the fused in sarcoma (FUS) gene, causing its mislocalization, are implicated in familial ALS.
- FUS plays a role in maintaining genome integrity and the DNA damage response (DDR).
Purpose of the Study:
- To investigate whether FUS regulates the expression of DNA damage response (DDR) factors.
- To explore the connection between FUS pathology, DDR signaling, and neurodegeneration in ALS.
Main Methods:
- Utilized RT2 PCR arrays to analyze DNA repair and DDR signaling pathways in FUS knockout/knockdown cells.
- Examined DDR factor expression in patient-derived induced pluripotent stem cell (iPSC)-derived motor neurons with FUS mutations.
- Analyzed postmortem spinal cord tissue from sporadic ALS patients with FUS pathology.
Main Results:
- Significant downregulation of BRCA1, DNA ligase 4, MSH complex, and RAD23B was observed in FUS-deficient cells.
- Similar downregulation patterns were found in iPSC-derived motor neurons and postmortem ALS tissues with FUS pathology.
- BRCA1 depletion is linked to DNA double-strand breaks and cognitive defects; RAD23B is involved in DNA repair and protein clearance.
Conclusions:
- FUS pathology perturbs DDR signaling through direct interactions and by affecting the expression of DDR genes.
- This study underscores the intricate link between FUS, genome instability, and neurodegeneration in ALS.
- FUS's role in regulating DDR gene expression is critical for neuronal health.
More Related Videos
07:14Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
